These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 27701692)

  • 21. A randomized clinical trial of alpha(1)-antitrypsin augmentation therapy.
    Dirksen A; Dijkman JH; Madsen F; Stoel B; Hutchison DC; Ulrik CS; Skovgaard LT; Kok-Jensen A; Rudolphus A; Seersholm N; Vrooman HA; Reiber JH; Hansen NC; Heckscher T; Viskum K; Stolk J
    Am J Respir Crit Care Med; 1999 Nov; 160(5 Pt 1):1468-72. PubMed ID: 10556107
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activity of the alpha-1 antitrypsin deficiency registry in Belgium.
    Hutsebaut J; Janssens W; Louis R; Willersinn F; Stephenne X; Sokal E; Derom E
    COPD; 2015 May; 12 Suppl 1():10-4. PubMed ID: 25938285
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Long-term therapy of alpha 1-antitrypsin-deficiency-associated pulmonary emphysema with human alpha 1-antitrypsin].
    Wencker M; Banik N; Buhl R; Seidel R; Konietzko N
    Pneumologie; 1998 Oct; 52(10):545-52. PubMed ID: 9847632
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of a novel SERPINA-1 mutation causing alpha-1 antitrypsin deficiency in a patient with severe bronchiectasis and pulmonary embolism.
    Milger K; Holdt LM; Teupser D; Huber RM; Behr J; Kneidinger N
    Int J Chron Obstruct Pulmon Dis; 2015; 10():891-7. PubMed ID: 26005342
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rationale and Design of the Genomic Research in Alpha-1 Antitrypsin Deficiency and Sarcoidosis Study. Alpha-1 Protocol.
    Strange C; Senior RM; Sciurba F; O'Neal S; Morris A; Wisniewski SR; Bowler R; Hochheiser HS; Becich MJ; Zhang Y; Leader JK; Methé BA; Kaminski N; Sandhaus RA;
    Ann Am Thorac Soc; 2015 Oct; 12(10):1551-60. PubMed ID: 26153726
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exploring the role of CT densitometry: a randomised study of augmentation therapy in alpha1-antitrypsin deficiency.
    Dirksen A; Piitulainen E; Parr DG; Deng C; Wencker M; Shaker SB; Stockley RA
    Eur Respir J; 2009 Jun; 33(6):1345-53. PubMed ID: 19196813
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activation of complement component 3 is associated with airways disease and pulmonary emphysema in alpha-1 antitrypsin deficiency.
    O'Brien ME; Fee L; Browne N; Carroll TP; Meleady P; Henry M; McQuillan K; Murphy MP; Logan M; McCarthy C; McElvaney OJ; Reeves EP; McElvaney NG
    Thorax; 2020 Apr; 75(4):321-330. PubMed ID: 31959730
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alpha 1-antitrypsin deficiency: memorandum from a WHO meeting.
    Bull World Health Organ; 1997; 75(5):397-415. PubMed ID: 9447774
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Augmentation Therapy for Severe Alpha-1 Antitrypsin Deficiency Improves Survival and Is Decoupled from Spirometric Decline-A Multinational Registry Analysis.
    Fraughen DD; Ghosh AJ; Hobbs BD; Funk GC; Meischl T; Clarenbach CF; Sievi NA; Schmid-Scherzer K; McElvaney OJ; Murphy MP; Roche AD; Clarke L; Strand M; Vafai-Tabrizi F; Kelly G; Gunaratnam C; Carroll TP; McElvaney NG
    Am J Respir Crit Care Med; 2023 Nov; 208(9):964-974. PubMed ID: 37624745
    [No Abstract]   [Full Text] [Related]  

  • 30. Augmentation therapy in alpha-1 antitrypsin deficiency: advances and controversies.
    Tonelli AR; Brantly ML
    Ther Adv Respir Dis; 2010 Oct; 4(5):289-312. PubMed ID: 20650978
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantitative disease progression model of α-1 proteinase inhibitor therapy on computed tomography lung density in patients with α-1 antitrypsin deficiency.
    Tortorici MA; Rogers JA; Vit O; Bexon M; Sandhaus RA; Burdon J; Chorostowska-Wynimko J; Thompson P; Stocks J; McElvaney NG; Chapman KR; Edelman JM
    Br J Clin Pharmacol; 2017 Nov; 83(11):2386-2397. PubMed ID: 28662542
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapeutic efficacy of α-1 antitrypsin augmentation therapy on the loss of lung tissue: an integrated analysis of 2 randomised clinical trials using computed tomography densitometry.
    Stockley RA; Parr DG; Piitulainen E; Stolk J; Stoel BC; Dirksen A
    Respir Res; 2010 Oct; 11(1):136. PubMed ID: 20920370
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alpha one antitrypsin deficiency: from gene to treatment.
    Wood AM; Stockley RA
    Respiration; 2007; 74(5):481-92. PubMed ID: 17671403
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alpha-1 antitrypsin deficiency.
    Primhak RA; Tanner MS
    Arch Dis Child; 2001 Jul; 85(1):2-5. PubMed ID: 11420185
    [No Abstract]   [Full Text] [Related]  

  • 35. [COPD and alpha-1-antitrypsin deficiency].
    Lara B
    Arch Bronconeumol; 2010; 46 Suppl 4():2-8. PubMed ID: 20850020
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Heritability of lung function in severe alpha-1 antitrypsin deficiency.
    DeMeo DL; Campbell EJ; Brantly ML; Barker AF; Eden E; McElvaney NG; Rennard SI; Stocks JM; Stoller JK; Strange C; Turino G; Sandhaus RA; Silverman EK
    Hum Hered; 2009; 67(1):38-45. PubMed ID: 18931508
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alpha-1-Antitrypsin Deficiency: Disease Management and Learning from Studies.
    Greulich T
    COPD; 2017 Mar; 14(sup1):S8-S11. PubMed ID: 28306355
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chronic obstructive pulmonary disease, with and without alpha-1-antitrypsin deficiency: management practices in the U.K.
    Hill AT; Campbell EJ; Ward AM; Stockley RA
    Respir Med; 1999 Jul; 93(7):481-90. PubMed ID: 10464835
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alpha-1-antitrypsin deficiency: diagnosis and treatment.
    Perlmutter DH
    Clin Liver Dis; 2004 Nov; 8(4):839-59, viii-ix. PubMed ID: 15464658
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term treatment of alpha1-antitrypsin deficiency-related pulmonary emphysema with human alpha1-antitrypsin. Wissenschaftliche Arbeitsgemeinschaft zur Therapie von Lungenerkrankungen (WATL)-alpha1-AT-study group.
    Wencker M; Banik N; Buhl R; Seidel R; Konietzko N
    Eur Respir J; 1998 Feb; 11(2):428-33. PubMed ID: 9551749
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.